Skip to main content
Premium Trial:

Request an Annual Quote

Moving About

A new study has found that a SARS-CoV-2 variant first identified in Southern California has now been found in other states and even other countries, KTLA reports.

Last month, researchers from Cedars-Sinai Medical Center reported that while testing patient samples from the region — which was experiencing a surge in COVID-19 cases — for the B.1.1.7 strain that had been uncovered in the UK, they instead found that a different strain, now dubbed CAL.20C, was prevalent there. The strain first popped up in July, but didn't take hold until later in the year. By December, it was present in a quarter of all COVID-19 cases in Southern California.

In the Journal of the American Medical Association, Cedars-Sinai-led researchers now say CAL.20C has spread outside of Southern California based on analysis of samples in the Global Initiative on Sharing All Influenza Data (GISAID) database. By January 2021, the strain was present in 19 states and Washington, DC, and six counties, they report.

"CAL.20C is moving, and we think it is Californians who are moving it," co-senior author Jasmine Plummer, a research scientist at Cedars-Sinai, says in a statement.

The CAL.20C strain has three variants that affect the spike protein, KTLA adds, and the researchers note that it is unclear whether CAL.20C is more deadly than other strains or whether it is more resistant to vaccines, but work into those questions is ongoing.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.